心臓血管補綴デバイス:医療機器パイプライン分析

◆英語タイトル:Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0183
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:290
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,260,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Cardiovascular Prosthetic Devices – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Cardiovascular Prosthetic Devices – Medical Devices Pipeline Assessment, 2019″ provides an overview of Cardiovascular Prosthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Prosthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiovascular Prosthetic Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiovascular Prosthetic Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiovascular Prosthetic Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 8
1.2 List of Figures 15
2 Introduction 17
2.1 Cardiovascular Prosthetic Devices Overview 17
3 Products under Development 18
3.1 Cardiovascular Prosthetic Devices – Pipeline Products by Stage of Development 18
3.2 Cardiovascular Prosthetic Devices – Pipeline Products by Segment 19
3.3 Cardiovascular Prosthetic Devices – Pipeline Products by Territory 20
3.4 Cardiovascular Prosthetic Devices – Pipeline Products by Regulatory Path 21
3.5 Cardiovascular Prosthetic Devices – Pipeline Products by Estimated Approval Date 22
3.6 Cardiovascular Prosthetic Devices – Ongoing Clinical Trials 23
4 Cardiovascular Prosthetic Devices – Pipeline Products under Development by Companies 24
4.1 Cardiovascular Prosthetic Devices Companies – Pipeline Products by Stage of Development 24
4.2 Cardiovascular Prosthetic Devices – Pipeline Products by Stage of Development 27
5 Cardiovascular Prosthetic Devices Companies and Product Overview 30
5.1 4Tech Cardio Ireland Ltd Company Overview 30
5.1.1 4Tech Cardio Ireland Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
5.2 Abbott Vascular Inc Company Overview 34
5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 34
5.3 Affluent Medical SA Company Overview 37
5.3.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 37
5.4 Ample Medical Inc Company Overview 41
5.4.1 Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.5 Ancora Heart Inc Company Overview 42
5.5.1 Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.6 Aporo Biomedical, Inc. (Inactive) Company Overview 46
5.6.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 AuriGen Medical Ltd Company Overview 47
5.7.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
5.8 BioStable Science & Engineering, Inc. Company Overview 48
5.8.1 BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.9 BioVentrix Inc Company Overview 51
5.9.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.10 CARAG AG Company Overview 55
5.10.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 55
5.11 Cardiac Dimensions Inc Company Overview 58
5.11.1 Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview 58
5.12 Cardiosolutions Inc Company Overview 61
5.12.1 Cardiosolutions Inc Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Celyad SA Company Overview 62
5.13.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Children’s Hospital Boston Company Overview 65
5.14.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 65
5.15 Cierra, Inc. (Inactive) Company Overview 68
5.15.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 68
5.16 Collplant Biotechnologies Ltd Company Overview 69
5.16.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
5.17 coramaze technologies GmbH Company Overview 70
5.17.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 70
5.18 CoreMedic AG Company Overview 71
5.18.1 CoreMedic AG Pipeline Products & Ongoing Clinical Trials Overview 71
5.19 CUBE SRL Company Overview 74
5.19.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 74
5.20 Daidalos Solutions BV Company Overview 75
5.20.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 75
6 Cardiovascular Prosthetic Devices- Recent Developments 182
6.1 Nov 20, 2019: FDA approves BioVentrix’s Revivent TC system 182
6.2 Nov 20, 2019: LivaNova to restructure its heart valve business line and End Caisson Transcatheter Mitral Valve Replacement Program 182
6.3 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 183
6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 185
6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 186
7 Appendix 287
7.1 Methodology 287
7.2 About GlobalData 290
7.3 Contact Us 290
7.4 Disclaimer 290

List of Tables
Table 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 18
Table 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment 19
Table 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory 20
Table 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 21
Table 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 22
Table 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 23
Table 7: Cardiovascular Prosthetic Devices Companies - Pipeline Products by Stage of Development 24
Table 8: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 27
Table 9: 4Tech Cardio Ireland Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
Table 10: TriCinch Coil Tricuspid Valve Repair System - Product Status 30
Table 11: TriCinch Coil Tricuspid Valve Repair System - Product Description 30
Table 12: 4Tech Cardio Ireland Ltd - Ongoing Clinical Trials Overview 31
Table 13: TriCinch Coil Tricuspid Valve Repair System - Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System 32
Table 14: TriCinch Coil Tricuspid Valve Repair System - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System 32
Table 15: TriCinch Coil Tricuspid Valve Repair System - Early Feasibility Study of TriCinch Coil Tricuspid Valve Repair System 32
Table 16: TriCinch Coil Tricuspid Valve Repair System - International Multisite Transcatheter Tricuspid Valve Therapies Registry 33
Table 17: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 34
Table 18: TriClip Device - Product Status 34
Table 19: TriClip Device - Product Description 34
Table 20: Abbott Vascular Inc - Ongoing Clinical Trials Overview 35
Table 21: TriClip Device - Clinical Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System Pivotal 36
Table 22: TriClip Device - Trial to Evaluate Treatment with Abbott Transcatheter Clip Repair System in Patients with Moderate or Greater Tricuspid Regurgitation (TRILUMINATE) 36
Table 23: Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 37
Table 24: Epygon - Product Status 37
Table 25: Epygon - Product Description 37
Table 26: Kalios - Product Status 38
Table 27: Kalios - Product Description 38
Table 28: Affluent Medical SA - Ongoing Clinical Trials Overview 39
Table 29: Kalios - OPTIMISE II: Optimisation of Surgical Repair for Treating Insufficiency of the Mitral Valve - Safety and Effectiveness Evaluation 40
Table 30: Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 31: PS3 System - Product Status 41
Table 32: PS3 System - Product Description 41
Table 33: Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 34: AccuCinch Ventriculoplasty System - Product Status 42
Table 35: AccuCinch Ventriculoplasty System - Product Description 42
Table 36: Ancora Heart Inc - Ongoing Clinical Trials Overview 43
Table 37: AccuCinch Ventriculoplasty System - A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch Ventricular Repair System - The CINCH-2 Study 44
Table 38: AccuCinch Ventriculoplasty System - An Early Feasibility Evaluation of the AccuCinch Ventricular Repair System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study 44
Table 39: AccuCinch Ventriculoplasty System - An Early Feasibility Study of the AccuCinch Ventricular Repair System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study 44
Table 40: AccuCinch Ventriculoplasty System - Early Feasibility Study of the AccuCinch Ventricular Repair System 45
Table 41: AccuCinch Ventriculoplasty System - Safety and Performance Evaluation of the AccuCinch Ventricular Repair System for Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study 45
Table 42: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
Table 43: Patent Foramen Ovale Closure Device - Product Status 46
Table 44: Patent Foramen Ovale Closure Device - Product Description 46
Table 45: AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
Table 46: Trans-Septal Implant - Product Status 47
Table 47: Trans-Septal Implant - Product Description 47
Table 48: BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 49: HAART 200 Aortic Annuloplasty Device - Product Status 48
Table 50: HAART 200 Aortic Annuloplasty Device - Product Description 48
Table 51: BioStable Science & Engineering, Inc. - Ongoing Clinical Trials Overview 49
Table 52: HAART 200 Aortic Annuloplasty Device - Safety and Performance of Aortic Valve Repair Using the HAART Aortic Annuloplasty Devices - A Registry Study 50
Table 53: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 54: Revivent-TC System - Product Status 51
Table 55: Revivent-TC System - Product Description 51
Table 56: BioVentrix Inc - Ongoing Clinical Trials Overview 52
Table 57: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy 53
Table 58: Revivent-TC System - Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms (ALIVE) 53
Table 59: Revivent-TC System - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy 53
Table 60: Revivent-TC System - Randomized Evaluation and Verification of Ventricular Enhancement: The REVIVE-HF Study 54
Table 61: CARAG AG Pipeline Products & Ongoing Clinical Trials Overview 55
Table 62: Carag BioResorbable Septal Occluder - Product Status 55
Table 63: Carag BioResorbable Septal Occluder - Product Description 55
Table 64: CARAG AG - Ongoing Clinical Trials Overview 56
Table 65: Carag BioResorbable Septal Occluder - Multi Centre, International, Post Market Registry to Monitor the Clinical Performance and Safety of an Atrial Septal Closure Device with Bioresorbable Framework in Patients with Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) in Routine Clinical Use 57
Table 66: Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 67: CARILLON Mitral Contour System - Product Status 58
Table 68: CARILLON Mitral Contour System - Product Description 58
Table 69: Cardiac Dimensions Inc - Ongoing Clinical Trials Overview 59

List of Figures
Figure 1: Cardiovascular Prosthetic Devices - Pipeline Products by Stage of Development 18
Figure 2: Cardiovascular Prosthetic Devices - Pipeline Products by Segment 19
Figure 3: Cardiovascular Prosthetic Devices - Pipeline Products by Territory 20
Figure 4: Cardiovascular Prosthetic Devices - Pipeline Products by Regulatory Path 21
Figure 5: Cardiovascular Prosthetic Devices - Pipeline Products by Estimated Approval Date 22
Figure 6: Cardiovascular Prosthetic Devices - Ongoing Clinical Trials 23

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心臓血管補綴デバイス:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆